Skip to main content

and
  1. Article

    Open Access

    An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy

    As the most common form of lymphoma, diffuse large B-cell lymphoma (DLBCL) is a clinical highly heterogeneous disease with variability in therapeutic outcomes and biological features. It is a challenge to iden...

    **glei Hu, **g Xu, Muqiao Yu, Yongchao Gao, Rong Liu in Journal of Translational Medicine (2020)

  2. Article

    Open Access

    Identification of gene modules associated with survival of diffuse large B-cell lymphoma treated with CHOP-based chemotherapy

    Diffuse Large B-cell Lymphoma (DLBCL), a heterogeneous disease, is influenced by complex network of gene interactions. Most previous studies focused on individual genes, but ignored the importance of intergeni...

    YongChao Gao, Bao Sun, **gLei Hu, Huan Ren, HongHao Zhou in The Pharmacogenomics Journal (2020)